Message from the Chair
The Department of Pathology is a founding department of the Stanford School of Medicine and one of the leading departments in the United States. Our preeminent faculty spans...
The Dorfman Kempson Fund
Empowering the Next Generation of Pathology Leaders
Help us empower the next generation of scientists to fully leverage all that this new era of discovery has to offer.
As these young scientists go out into the world, the intellectual independence and entrepreneurial fire they gained at Stanford will go with them, and the impact of their achievements will resonate around the globe.
A simple blood test that analyzes immune function can forecast how quickly a person undergoing hip replacement surgery will recover.
In large study of dialysis patients, low immune response to the COVID-19 vaccine made by Johnson & Johnson indicates that a booster shot might be needed.
Stanford School of Medicine’s new health policy department will be a hub for research and education on the causes of and solutions to health inequities.
A comprehensive study of immune responses to SARS-CoV-2 associates mild disease with comparatively high levels of antibodies that target the viral spike protein. But all antibodies wane within months.
Stanford pathologist in the news: Stanford leaders and health experts detail university’s COVID-19 surveillance testing program…